Antara Capital LP

CIK

1750183

Location

New York, NY

Portfolio Value

Micro $26,782

Diversification

Highly concentrated

Filing Date

Global Rank

#8,744 / 8,753 ▼ 739 · as of Dec 2025

Top Industry

Biotechnology 100.0%

3Y Alpha vs SPY

+6.9%

Period ended 8 months ago

Filed Feb 17, 2026 · 7mo

24 quarters · since Mar 2020

Clone Performance

Sep 2023–Jul 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Not a measure of this manager's performance. Most of Antara Capital LP's reported book is option positions, which a stock-only clone cannot replicate. The figures below are the return of the 52% that is ordinary stock — as little as 0% in one quarter — so a manager whose options thesis lost money can still show a large gain here.

Cloned portfolio

+95.6%

SPY

+66.6%

Annualised alpha

+6.9%

Max drawdown

−96.0%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends. Captured split ratios restate closes onto one basis; only an unusable ratio can exclude earlier closes for that listing. It tracks 52% of reported value on average across 11 quarters.Antara Capital LP has stopped filing, so the simulation ends in Jul 2026 — where its last reported portfolio went stale — rather than trading that portfolio forward to today. Past performance does not predict future results.

Portfolio Concentration

1 tracked positions · as of Dec 31, 2025 · Δ vs Sep 30, 2025

Top Position

100.0%

+8.6 pts

Top 5

100.0%

0.0 pts

Top 10

100.0%

0.0 pts

HHI

10,000

Highly concentrated+1,578

Portfolio Trend

24 quarters · across all stocks

Sector Breakdown

As of Dec 31, 2025

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$26,782	1

Last Quarter's Activity

Export CSV

Dec 31, 2025 vs Sep 30, 2025

Added To

Positions the filer increased

No qualifying positions this quarter.

Trimmed

Positions the filer reduced

No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter

No qualifying positions this quarter.

Sold Out

Positions the filer fully exited

1 positions

Ticker	Company	Shares	Value	Open
CURR	Currenc Group Inc.	263,200	$442,176
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

1 tracked positions · $26,782 total · filing declares 2 positions · $30,189 · as of Dec 31, 2025

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio	History
ASBP	Aspire Biopharma Holdings, Inc. Healthcare	Held	410,590	0	$26,782	−35.9%	100.00%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.